<?xml version="1.0" encoding="UTF-8"?>
<app-group>
 <app id="app1-ijerph-16-04638">
  <title>Appendix A</title>
 </app>
 <app id="app2-ijerph-16-04638">
  <title>Appendix B. Questionnaire for Checking on Eligibility Criteria</title>
  <p>Title of article: ……………………………………………………………..………………………… Author: …………………………………… Year of publication: …………………</p>
  <list list-type="simple">
   <list-item>
    <label>
     <bold>a.</bold> 
    </label>
    <p>Type of screening (entry, exit) 
     <bold>Yes</bold>
     <bold>☐ No</bold>
     <bold>☐</bold>
    </p>
   </list-item>
   <list-item>
    <label>
     <bold>b.</bold> 
    </label>
    <p>Types of infectious disease or diseases that entry and exit screening was targeting 
     <bold>Yes</bold>
     <bold>☐ No</bold>
     <bold>☐</bold>
    </p>
   </list-item>
   <list-item>
    <label>
     <bold>c.</bold> 
    </label>
    <p>Type of points of entry (airports, ports, ground crossings) where measures were implemented 
     <bold>Yes</bold>
     <bold>☐ No</bold>
     <bold>☐</bold>
    </p>
   </list-item>
   <list-item>
    <label>
     <bold>d.</bold> 
    </label>
    <p>Screening carried out on a routine basis or on an ad hoc basis after a public health event has occurred and its purpose 
     <bold>Yes</bold>
     <bold>☐ No</bold>
     <bold>☐</bold>
    </p>
   </list-item>
   <list-item>
    <label>
     <bold>e.</bold> 
    </label>
    <p>Description of methods used in entry/exit screening (primary/secondary, questionnaire, body temperature check, technology used) 
     <bold>Yes</bold>
     <bold>☐ No</bold>
     <bold>☐</bold>
    </p>
   </list-item>
   <list-item>
    <label>
     <bold>f.</bold> 
    </label>
    <p>Type of technology used (thermometers, scan cameras, or other technology)</p>
   </list-item>
   <list-item>
    <label>
     <bold>g.</bold> 
    </label>
    <p>After screening, the applied diagnosis protocol (laboratory and clinical examination)</p>
   </list-item>
   <list-item>
    <label>
     <bold>h.</bold> 
    </label>
    <p>Number of cases identified for a specific timeframe 
     <bold>Yes</bold>
     <bold>☐ No</bold>
     <bold>☐</bold>
    </p>
   </list-item>
   <list-item>
    <label>
     <bold>i.</bold> 
    </label>
    <p>Total numbers of travelers screened for a specific timeframe 
     <bold>Yes</bold>
     <bold>☐ No</bold>
     <bold>☐</bold>
    </p>
   </list-item>
   <list-item>
    <label>
     <bold>j.</bold> 
    </label>
    <p>Percentage of persons positive to screening that were diagnosed with the targeted disease 
     <bold>Yes</bold>
     <bold>☐ No</bold>
     <bold>☐</bold>
    </p>
   </list-item>
   <list-item>
    <label>
     <bold>k.</bold> 
    </label>
    <p>Percentage of persons diagnosed with different disease from the initially targeted for the specific timeframe (positive and negative predictive values) 
     <bold>Yes</bold>
     <bold>☐ No</bold>
     <bold>☐</bold>
    </p>
   </list-item>
   <list-item>
    <label>
     <bold>l.</bold> 
    </label>
    <p>General screening or targeted screening (e.g., traveler from any affected outbound country, all travelers directly arriving only from affected countries/areas, nationality of travelers, travelers in-transit that have called an affected country/areas (West Africa)) 
     <bold>Yes</bold>
     <bold>☐ No</bold>
     <bold>☐</bold>
    </p>
   </list-item>
   <list-item>
    <label>
     <bold>m.</bold> 
    </label>
    <p>Reporting on the assessment of the public health impact of the entry/exit screening measures or the cost-effectiveness of methods applied</p>
   </list-item>
  </list>
 </app>
 <app id="app3-ijerph-16-04638">
  <title>Appendix C. Questionnaire for Data Extraction</title>
  <list list-type="alpha-lower">
   <list-item>
    <p>Type of screening: entry ☐ exit ☐</p>
   </list-item>
   <list-item>
    <p>Types of infectious disease or diseases that entry and exit screening was targeting </p>
   </list-item>
   <list-item>
    <p>Type of points of entry: airports ☐ ports ☐ ground crossings ☐</p>
   </list-item>
   <list-item>
    <p>Screening carried out on a routine basis ☐ or on an ad hoc basis ☐ after a public health event has occurred</p>
   </list-item>
   <list-item>
    <p>Methods used in entry/exit screening: primary ☐ secondary ☐ questionnaire ☐ body temperature ☐ technology used ☐ else </p>
   </list-item>
   <list-item>
    <p>Type of technology used: thermometers scan cameras </p>
   </list-item>
   <list-item>
    <p>After screening, the applied diagnosis protocol (laboratory and clinical examination)</p>
   </list-item>
   <list-item>
    <p>Number of cases identified and the total numbers of travelers screened </p>
   </list-item>
   <list-item>
    <p>Percentage of persons positive to screening finally diagnosed </p>
   </list-item>
   <list-item>
    <p>Percentage of persons diagnosed with different disease from the initially targeted</p>
   </list-item>
   <list-item>
    <p>The applied protocol after diagnosis and management of cases</p>
   </list-item>
   <list-item>
    <p>Health measures applied to the traveler and the environment </p>
   </list-item>
   <list-item>
    <p>General screening or targeted screening: outbound country ☐ travelers directly arriving from affected countries ☐ nationality ☐ travelers in-transit ☐</p>
   </list-item>
   <list-item>
    <p>Inter-sectorial collaboration and coordination processes </p>
   </list-item>
   <list-item>
    <p>Involved officers: Public health officers ☐ ministry officers ☐ regional health system ☐ national health system ☐ NGOs ☐ else ☐</p>
   </list-item>
   <list-item>
    <p>Concrete example of entry/exit screening </p>
   </list-item>
   <list-item>
    <p>Practices, experiences, and lessons learnt reported</p>
   </list-item>
   <list-item>
    <p>Challenges reported (limitations, failures, mishaps)</p>
   </list-item>
   <list-item>
    <p>Bad practices reported</p>
   </list-item>
   <list-item>
    <p>Methods used to assess the public health impact of the entry/exit screening and their result </p>
   </list-item>
   <list-item>
    <p>Methods used to appraise the cost-effectiveness of screening method and results</p>
   </list-item>
   <list-item>
    <p>Evaluation of method results: sensitivity ☐ specificity ☐ false positive/negative ☐ (of screening method) ☐ positive and negative predictive values</p>
   </list-item>
   <list-item>
    <p>Decision-making level: Public health officers ☐ ministry officers ☐ regional ☐ national ☐ intersectoral collaboration ☐ health and border authorities ☐</p>
   </list-item>
   <list-item>
    <p>Communication channels </p>
   </list-item>
   <list-item>
    <p>Notification practices between neighboring and possibly affected countries</p>
   </list-item>
   <list-item>
    <p>Specific timeframe referred Yes ☐ No ☐ Duration:</p>
   </list-item>
  </list>
 </app>
 <app id="app4-ijerph-16-04638">
  <title>Appendix D. List of Publications Identified through the Scoping Search</title>
  <disp-formula>
   <bold>A
    <sc>ssessment for imported cases notification of infectious diseases</sc>
   </bold>
  </disp-formula>
  <p>CHIEN-HUA CHU, J. H., YA-LING CHEN, CHE-CHIEH YEN, 2011. Study on the Notification of Imported Cases of Notifiable Diseases by Using the Data in the National Health Insurance Information System during 2007–2008. Taiwan Epidemiology Bulletin, 27, 19–38.</p>
  <disp-formula>
   <bold>D
    <sc>engue entry screening at airports</sc>
   </bold>
  </disp-formula>
  <p>KUAN, M. M. &amp; CHANG, F. Y. 2012. Airport sentinel surveillance and entry quarantine for Dengue infections following a fever screening program in Taiwan. BMC Infect Dis, 12, 182.</p>
  <p>SHU, P. Y., CHIEN, L. J., CHANG, S. F., SU, C. L., KUO, Y. C., LIAO, T. L., HO, M. S., LIN, T. H. &amp; HUANG, J. H. 2005. Fever screening at airports and imported Dengue. Emerging Infectious Diseases, 11, 460–462.</p>
  <disp-formula>
   <bold>E
    <sc>bola</sc> V
    <sc>irus</sc> D
    <sc>isease</sc>
   </bold>
  </disp-formula>
  <p>
   <bold>Preparedness and response planning for Ebola Virus Disease</bold>
  </p>
  <p>BROSH-NISSIMOV, T., POLES, L., KASSIRER, M., SINGER, R., KALINER, E., SHRIKI, D. D., ANIS, E., FOGEL, I., ENGELHARD, D., GROTTO, I. &amp; ISRAELI EPIDEMIC MANAGEMENT, T. 2015. Preparing for imported Ebola cases in Israel, 2014 to 2015. Euro Surveill, 20.</p>
  <p>DEMOCRATIC REPUBLIC OF THE CONGO 2018. Strategic response plan for the Ebola virus disease outbreak.</p>
  <p>ECDC 2014. Technical report: Infection prevention and control measures for Ebola virus disease Entry and exit screening measures.</p>
  <p>ECDC 2015. Mission Report: Public health emergency preparedness for cases of viral hemorrhagic fever (Ebola) in Belgium: a peer review-16–19 March 2015.</p>
  <p>FRIEDEN, T. R. &amp; DAMON, I. K. 2015. Ebola in West Africa—CDC’s Role in Epidemic Detection, Control, and Prevention. Emerg Infect Dis, 21, 1897-905.</p>
  <p>NUNN, R., JAWAD, M., CRUICKSHANK, H., POOLE, R., VASS, C. &amp; FRASER, S. 2015. Perspectives on Ebola screening at ports of entry in the UK. Perspect Public Health, 135, 66–67.</p>
  <p>WORLD HEALTH ORGANISATION 2014a. Exit Screening Ebola Guidance Package.</p>
  <p>WORLD HEALTH ORGANISATION 2014b. Technical note for Ebola virus disease preparedness planning for entry screening at airports, ports, and land crossings.</p>
  <p>WORLD HEALTH ORGANISATION 2014c. WHO Interim Guidance for Ebola Virus Disease: Exit Screening at Airports, Ports, and Land Crossings.</p>
  <p>WORLD HEALTH ORGANISATION 2014d. WHO Interim Guidance for Ebola Event Management at Points of Entry.</p>
  <p>WORLD HEALTH ORGANISATION 2018d. WHO Regional Strategic EVD Readiness Preparedness Plan.</p>
  <p>
   <bold>Entry/exit screening measures for Ebola Virus Disease experience</bold>
  </p>
  <p>BROWN, C. M., ARANAS, A. E., BENENSON, G. A., BRUNETTE, G., CETRON, M., CHEN, T. H., COHEN, N. J., DIAZ, P., HABER, Y., HALE, C. R., HOLTON, K., KOHL, K., LE, A. W., PALUMBO, G. J., PEARSON, K., PHARES, C. R., ALVARADO-RAMY, F., ROOHI, S., ROTZ, L. D., TAPPERO, J., WASHBURN, F. M., WATKINS, J., PESIK, N., CENTERS FOR DISEASE, C. &amp; PREVENTION 2014. Airport exit and entry screening for Ebola--August-November 10, 2014. MMWR Morb Mortal Wkly Rep, 63, 1163–1167.</p>
  <p>CARDILE, A. P., MURRAY, C. K., LITTELL, C. T., SHAH, N. J., FANDRE, M. N., DRINKWATER, D. C., MARKELZ, B. P. &amp; VENTO, T. J. 2015. Monitoring Exposure to Ebola and Health of US Military Personnel Deployed in Support of Ebola Control Efforts - Liberia, October 25, 2014–February 27, 2015. MMWR Morb Mortal Wkly Rep, 64, 690–694.</p>
  <p>CDC 2015. Interim Table of State Ebola Screening and Monitoring Policies for Asymptomatic Individuals.</p>
  <p>CHAN, J., PATEL, M., TOBIN, S. &amp; SHEPPEARD, V. 2017. Monitoring travelers from Ebola-affected countries in New South Wales, Australia: what is the impact on travelers? BMC Public Health, 17, 113. </p>
  <p>COHEN, N. J., BROWN, C. M., ALVARADO-RAMY, F., BAIR-BRAKE, H., BENENSON, G. A., CHEN, T. H., DEMMA, A. J., HOLTON, N. K., KOHL, K. S., LEE, A. W., MCADAM, D., PESIK, N., ROOHI, S., SMITH, C. L., WATERMAN, S. H. &amp; CETRON, M. S. 2016. Travel and Border Health Measures to Prevent the International Spread of Ebola. MMWR Suppl, 65, 57–67.</p>
  <p>CROOK, P., SMITH-PALMER, A., MAGUIRE, H., MCCARTHY, N., KIRKBRIDE, H., COURT, B., KANAGARAJAH, S., TURBITT, D., AHMED, S., COSFORD, P. &amp; OLIVER, I. 2017. Lack of Secondary Transmission of Ebola Virus from Healthcare Worker to 238 Contacts, United Kingdom, December 2014. Emerg Infect Dis, 23, 2081–2084.</p>
  <p>GILBERT, G. L. 2016. Australia’s response to Ebola Virus disease in West Africa, 2014–2015. Public Health Res Pract, 26.</p>
  <p>GULLAND, A. 2014. Experts question usefulness of screening travelers to UK for Ebola. BMJ, 349, g6199.</p>
  <p>JACOBSON, S. H., YU, G. &amp; JOKELA, J. A. 2016. A double-risk monitoring and movement restriction policy for Ebola entry screening at airports in the United States. Prev Med, 88, 33–38.</p>
  <p>KALRA, S., KELKAR, D., GALWANKAR, S. C., PAPADIMOS, T. J., STAWICKI, S. P., ARQUILLA, B., HOEY, B. A., SHARPE, R. P., SABOL, D. &amp; JAHRE, J. A. 2014. The emergence of Ebola as a global health security threat: from ‘lessons learnt’ to coordinated multilateral containment efforts. J Glob Infect Dis, 6, 164–177.</p>
  <p>KEITA, M., CONTE, F., DIALLO, B., LUFWA, D., KATOMBA, J., SNACKEN, R., PALLAWO, R., TOLNO, A., DIALLO, A. B., DJINGAREY, M. H. &amp; SUBISSI, L. 2017. Lessons learnt by surveillance during the tail-end of the Ebola outbreak in Guinea, June-October 2015: a case series. BMC Infect Dis, 17, 304.</p>
  <p>KESTEN, J. M., AUDREY, S., HOLDING, M., COOPE, C., YOUNG, N., BROWN, C. S., HARRIES, J., HICKMAN, M. &amp; OLIVER, I. 2018. Qualitative study of Ebola screening at ports of entry to the UK. BMJ Glob Health, 3, e000788.</p>
  <p>C., HARVEY, M. C., PIETZ, H., BERTOLLI, J., PERZ, J. F., WHITNEY, C. G., HALPIN, A. S., DALEY, W. R., PESIK, N., MARGOLIS, G. S., TUMPEY, A., TAPPERO, J., DAMON, I., CENTERS FOR DISEASE, C. &amp; PREVENTION 2015. Systems for rapidly detecting and treating persons with ebola virus disease--United States. MMWR Morb Mortal Wkly Rep, 64, 222–225.</p>
  <p>KOONIN, L. M., JAMIESON, D. J., JERNIGAN, J. A., VAN BENEDEN, C. A., KOSMOS, </p>
  <p>KRAEMER, J. D., SIEDNER, M. J. &amp; STOTO, M. A. 2015. Analyzing Variability in Ebola-Related Controls Applied to Returned Travelers in the United States. Health Secur, 13, 295–306.</p>
  <p>MCCARTHY, M. 2014. US increases Ebola screening at five airports. BMJ, 349, g6147.</p>
  <p>MILLMAN, A. J., CHAMANY, S., GUTHARTZ, S., THIHALOLIPAVAN, S., PORTER, M., SCHROEDER, A., VORA, N. M., VARMA, J. K. &amp; STARR, D. 2016. Active Monitoring of Travelers Arriving from Ebola-Affected Countries - New York City, October 2014–April 2015. MMWR Morb Mortal Wkly Rep, 65, 51–54.</p>
  <p>MIRKOVIC, K., THWING, J., DIACK, P. A., CENTERS FOR DISEASE, C. &amp; PREVENTION 2014. Importation and containment of Ebola virus disease - Senegal, August-September 2014. MMWR Morb Mortal Wkly Rep, 63, 873–874.</p>
  <p>MOLL, R., REECE, S., COSFORD, P. &amp; KESSEL, A. 2016. The Ebola epidemic and public health response. Br Med Bull, 117, 15–23.</p>
  <p>NYENSWAH, T. G., KATEH, F., BAWO, L., MASSAQUOI, M., GBANYAN, M., FALLAH, M., NAGBE, T. K., KARSOR, K. K., WESSEH, C. S., SIEH, S., GASASIRA, A., GRAAFF, P., HENSLEY, L., ROSLING, H., LO, T., PILLAI, S. K., GUPTA, N., MONTGOMERY, J. M., RANSOM, R. L., WILLIAMS, D., LANEY, A. S., LINDBLADE, K. A., SLUTSKER, L., TELFER, J. L., CHRISTIE, A., MAHONEY, F. &amp; DE COCK, K. M. 2016. Ebola and Its Control in Liberia, 2014-2015. Emerg Infect Dis, 22, 169–177.</p>
  <p>PARHAM, M., EDISON, L., SOETEBIER, K., FELDPAUSCH, A., KUNKES, A., SMITH, W., GUFFEY, T., FETHEROLF, R., SANLIS, K., GABEL, J., COWELL, A., DRENZEK, C., CENTERS FOR DISEASE, C. &amp; PREVENTION 2015. Ebola active monitoring system for travelers returning from West Africa-Georgia, 2014-2015. MMWR Morb Mortal Wkly Rep, 64, 347–350.</p>
  <p>PUBLIC HEALTH AGENCY OF CANADA 2014. Statement on infection prevention and control measures for Ebola virus disease (December 2014). Can Nurse, 110, 17-8.</p>
  <p>READ, J. M., DIGGLE, P. J., CHIROMBO, J., SOLOMON, T. &amp; BAYLIS, M. 2015. Effectiveness of screening for Ebola at airports. Lancet, 385, 23-24.</p>
  <p>SAITO, T. 2015. Public health challenges and legacies of Japan’s response to the Ebola virus disease outbreak in West Africa 2014 to 2015. Eurosurveillance, 20, 25–30.</p>
  <p>SHUAIB, F., GUNNALA, R., MUSA, E. O., MAHONEY, F. J., OGUNTIMEHIN, O., NGUKU, P. M., NYANTI, S. B., KNIGHT, N., GWARZO, N. S., IDIGBE, O., NASIDI, A., VERTEFEUILLE, J. F., CENTERS FOR DISEASE, C. &amp; PREVENTION 2014. Ebola virus disease outbreak—Nigeria, July–September 2014. MMWR Morb Mortal Wkly Rep, 63, 867–872.</p>
  <p>STEHLING-ARIZA, T., FISHER, E., VAGI, S., FECHTER-LEGGETT, E., PRUDENT, N., DOTT, M., DALEY, R. &amp; AVCHEN, R. N. 2015. Monitoring of Persons with Risk for Exposure to Ebola Virus Disease - United States, November 3, 2014-March 8, 2015. MMWR Morb Mortal Wkly Rep, 64, 685–689.</p>
  <p>SUNSHINE, G., PEPIN, D., CETRON, M. &amp; PENN, M. 2015. State and Territorial Ebola Screening, Monitoring, and Movement Policy Statements - United States, August 31, 2015. MMWR Morb Mortal Wkly Rep, 64, 1145–1146.</p>
  <p>WHO-ICAO 2014. Joint Statement on EVD outbreak.</p>
  <p>
   <bold>Studies about evolution and predictions of Ebola Virus Disease spread</bold>
  </p>
  <p>ARWADY, M. A., BAWO, L., HUNTER, J. C., MASSAQUOI, M., MATANOCK, A., DAHN, B., AYSCUE, P., NYENSWAH, T., FORRESTER, J. D., HENSLEY, L. E., MONROE, B., SCHOEPP, R. J., CHEN, T. H., SCHAECHER, K. E., GEORGE, T., ROUSE, E., SCHAFER, I. J., PILLAI, S. K. &amp; DE COCK, K. M. 2015. Evolution of ebola virus disease from exotic infection to global health priority, Liberia, mid-2014. Emerg Infect Dis, 21, 578–584.</p>
  <p>BOGOCH, II, CREATORE, M. I., CETRON, M. S., BROWNSTEIN, J. S., PESIK, N., MINIOTA, J., TAM, T., HU, W., NICOLUCCI, A., AHMED, S., YOON, J. W., BERRY, I., HAY, S. I., ANEMA, A., TATEM, A. J., MACFADDEN, D., GERMAN, M. &amp; KHAN, K. 2015. Assessment of the potential for international dissemination of Ebola virus via commercial air travel during the 2014 west African outbreak. Lancet, 385, 29–35.</p>
  <p>INTERNATIONAL CIVIL AVIATION ORGANISATION 2014. Recognizing the role of aviation in the Ebola outbreak and other public health emergencies. 51st Conference of Directors General of Civil Aviation Asia and pacific Regions.</p>
  <p>
   <bold>E
    <sc>ntry</sc>/
    <sc>exit screening measures for infectious diseases</sc>
   </bold>
  </p>
  <p>BITAR D, G. A., DESENCLOS J C, 2009. International travels and fever screening during epidemics: A literature review on the effectiveness and potential use of non-contact infrared thermometers. Eurosurveillance, 14.</p>
  <p>CHO, K. S. &amp; YOON, J. 2014. Fever Screening and Detection of Febrile Arrivals at an International Airport in Korea: Association among Self-reported Fever, Infrared Thermal Camera Scanning, and Tympanic Temperature. Epidemiol Health, 36, e2014004.</p>
  <p>GABER, W., GOETSCH, U., DIEL, R., DOERR, H. W. &amp; GOTTSCHALK, R. 2009. Screening for infectious diseases at international airports: the Frankfurt model. Aviat Space Environ Med, 80, 595–600.</p>
  <p>GUANGHAO SUN, N. Q. V., SHIGETO ABE, OSAMU TAKEI, MASAMI SUGAMATA, TAKEMI MATSUI, 2013. A Portable Infection Screening System Designed for Onboard Entry Screening Based on Multi-Parameter Vital Signs. International Journal of E-Health and Medical Communications, 3, 20–30.</p>
  <p>HUIZER, Y.L., SWAAM, C.M., LEITMEYER, K.C. &amp; TIMEN, A. 2014. Usefulness and applicability of infectious disease control measures in air travel: A review. Travel Med Infect Dis, 13(1), 19–30</p>
  <p>JEFFERSON, T., DEL MAR, C., DOOLEY, L., FERRONI, E., AL-ANSARY, L. A., BAWAZEER, G. A., VAN DRIEL, M. L., FOXLEE, R. &amp; RIVETTI, A. 2009. Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review. BMJ, 339, b3675.</p>
  <p>JONES, J., GASTELLU-ETCHEGORRY, M., STENZ, F. K., BAUDON, C., BLOEM, S. J., BONDONNEAU, M., COHUET, S., DIGGLE, R., EWING, R. W., GERSTENBLUTH, I., GRANGEON, J. P., KUMAR ALLA, K., LAJOINIE, G., TROMP, M., TUMAHAI, T., YVON, J. F., SWAAN, C. M. &amp; GOSSNER, C. M. 2011. Epidemiology, surveillance and control of infectious diseases in the European overseas countries and territories, 2011. Euro Surveill, 16.</p>
  <p>KRISHNAMURTHY, R., REMIS, M., BROOKE, L., MILLER, C., NAVIN, A. &amp; GUERRA, M. 2006. Quarantine Activity Reporting System (QARS). AMIA Annu Symp Proc, 990.</p>
  <p>MCBRIDE, W. J., BUIKSTRA, E. &amp; FITZGERALD, M. 2010. Investigation of febrile passengers detected by infrared thermal scanning at an international airport. Aust N Z J Public Health, 34, 5–10.</p>
  <p>MERRILL, R. D., ROGERS, K., WARD, S., OJO, O., KAKAI, C. G., AGBEKO, T. T., GARBA, H., MACGURN, A., OPPERT, M., KONE, I., BAMSA, O., SCHNEIDER, D. &amp; BROWN, C. 2017. Responding to Communicable Diseases in Internationally Mobile Populations at Points of Entry and along Porous Borders, Nigeria, Benin, and Togo. Emerg Infect Dis, 23.</p>
  <p>SELVEY, L. A., ANTAO, C. &amp; HALL, R. 2015. Entry screening for infectious diseases in humans. Emerg Infect Dis, 21, 197–201.</p>
  <p>SUN, G., ABE, N., SUGIYAMA, Y., NGUYEN, Q. V., NOZAKI, K., NAKAYAMA, Y., TAKEI, O., HAKOZAKI, Y., ABE, S. &amp; MATSUI, T. 2013. Development of an infection screening system for entry inspection at airport quarantine stations using ear temperature, heart and respiration rates. Conf Proc IEEE Eng Med Biol Soc, 2013, 6716–6719.</p>
  <p>
   <bold>I
    <sc>nfluenza</sc>
   </bold>
  </p>
  <p>CHEN, J., YANG, K., ZHANG, M., SHEN, C., CHEN, J., WANG, G., HUANG, S., ZHANG, M., XIONG, H., CHEN, H., CHEN, Y. &amp; XIA, N. 2018. Rapid identification of imported influenza viruses at Xiamen International Airport via an active surveillance program. Clin Microbiol Infect, 24, 289–294.</p>
  <p>COWLING, B. J., LAU, L. L., WU, P., WONG, H. W., FANG, V. J., RILEY, S. &amp; NISHIURA, H. 2010. Entry screening to delay local transmission of 2009 pandemic influenza A (H1N1). BMC Infect Dis, 10, 82. </p>
  <p>FUJITA, M., SATO, H., KAKU, K., TOKUNO, S., KANATANI, Y., SUZUKI, S. &amp; SHINOMIYA, N. 2011. Airport quarantine inspection, follow-up observation, and the prevention of pandemic influenza. Aviat Space Environ Med, 82, 782–789.</p>
  <p>GOMEZ, J., MUNAYCO, C. V., ARRASCO, J. C., SUAREZ, L., LAGUNA-TORRES, V. A., AGUILAR, P. V., CHOWELL, G. &amp; KOCHEL, T. J. 2009. Pandemic Influenza in a Southern Hemisphere Setting: The Experience in Peru from May to September, 2009. Eurosurveillance, 14, 22–27.</p>
  <p>GUNARATNAM, P. J., TOBIN, S., SEALE, H., MARICH, A. &amp; MCANULTY, J. 2014. Airport arrivals screening during pandemic (H1N1) 2009 influenza in New South Wales, Australia. Med J Aust, 200, 290–292.</p>
  <p>HALE, M. J., HOSKINS, R. S. &amp; BAKER, M. G. 2012. Screening for influenza A(H1N1)pdm09, Auckland International Airport, New Zealand. Emerg Infect Dis, 18, 866–868. </p>
  <p>JIUN-SHIAN KUO, Y.-H. L., JUI-WEI HSIEH, MIN-CHENG LIN, SHIH-YAN YANG, 2009. Initial Evaluation on Screening of Novel Influenza A (H1N1) at International Ports in Taiwan. Taiwan Epidemiology Bulletin, 25, 626–647.</p>
  <p>KHAN, K., ECKHARDT, R., BROWNSTEIN, J. S., NAQVI, R., HU, W., KOSSOWSKY, D., SCALES, D., ARINO, J., MACDONALD, M., WANG, J., SEARS, J. &amp; CETRON, M. S. 2013. Entry and exit screening of airline travelers during the A(H1N1) 2009 pandemic: a retrospective evaluation. Bull World Health Organ, 91, 368–376.</p>
  <p>LYTRAS, T., THEOCHAROPOULOS, G., TSIODRAS, S., MENTIS, A., PANAGIOTOPOULOS, T., BONOVAS, S. &amp; INFLUENZA SURVEILLANCE REPORT, G. 2009. Enhanced surveillance of influenza A(H1N1)v in Greece during the containment phase. Euro Surveill, 14.</p>
  <p>MUKHERJEE, P., LIM, P. L., CHOW, A., BARKHAM, T., SEOW, E., WIN, M. K., CHUA, A., LEO, Y. S. &amp; CHENG CHEN, M. I. 2010. Epidemiology of travel-associated pandemic (H1N1) 2009 infection in 116 patients, Singapore. Emerg Infect Dis, 16, 21–26.</p>
  <p>NISHIURA, H. &amp; KAMIYA, K. 2011. Fever screening during the influenza (H1N1-2009) pandemic at Narita International Airport, Japan. BMC Infect Dis, 11, 111.</p>
  <p>NISHIURA, H., WILSON, N. &amp; BAKER, M. G. 2009. Quarantine for pandemic influenza control at the borders of small island nations. BMC Infectious Diseases, 9.</p>
  <p>PRIEST, P. C., DUNCAN, A. R., JENNINGS, L. C. &amp; BAKER, M. G. 2011. Thermal image scanning for influenza border screening: results of an airport screening study. PLoS One, 6, e14490.</p>
  <p>PRIEST, P. C., JENNINGS, L. C., DUNCAN, A. R., BRUNTON, C. R. &amp; BAKER, M. G. 2013. Effectiveness of border screening for detecting influenza in arriving airline travelers. Am J Public Health, 103, 1412–1418.</p>
  <p>SAKAGUCHI, H., TSUNODA, M., WADA, K., OHTA, H., KAWASHIMA, M., YOSHINO, Y. &amp; AIZAWA, Y. 2012. Assessment of Border Control Measures and Community Containment Measures Used in Japan during the Early Stages of Pandemic (H1N1) 2009. Plos One, 7.</p>
  <p>SCHLAICH, C., SEVENICH, C. &amp; GAU, B. 2012. [Public health measures at the airport of Hamburg during the early phase of pandemic influenza (H1N1) 2009]. Gesundheitswesen, 74, 145–153.</p>
  <p>SHIMADA, T., GU, Y., KAMIYA, H., KOMIYA, N., ODAIRA, F., SUNAGAWA, T., TAKAHASHI, H., TOYOKAWA, T., TSUCHIHASHI, Y., YASUI, Y., TADA, Y. &amp; OKABE, N. 2009. Epidemiology of influenza A(H1N1)v virus infection in Japan, May-June 2009. Euro Surveill, 14.</p>
  <p>WORLD HEALTH ORGANISATION 2009a. Responding to New Influenza A(H1N1): Options for interventions at international points of entry (interim option paper). In: PACIFIC, W. R. O. F. T. W. (ed.).</p>
  <p>WORLD HEALTH ORGANISATION 2009b. WHO technical advice for case management of Influenza A(H1N1) in air transport, Developed in cooperation with The International Civil Aviation Organisation and The International Air Transport Association.</p>
  <p>WORLD HEALTH ORGANISATION 2010b. Public health measures taken at international borders during early stages of pandemic influenza A (H1N1) 2009: preliminary results. Weekly epidemiological record, 21.</p>
  <p>ZHANG, Y., YANG, P., LIYANAGE, S., SEALE, H., DENG, Y., PANG, X., TIAN, L., LIU, B., ZHANG, L. &amp; WANG, Q. 2012. The characteristics of imported cases and the effectiveness of outbreak control strategies of pandemic influenza A (H1N1) in China. Asia Pac J Public Health, 24, 932–939.</p>
  <p>
   <bold>Pandemic influenza preparedness</bold>
  </p>
  <p>BELL, D., NICOLL, A., FUKUDA, K., HORBY, P., MONTO, A. &amp; GRP, W. H. O. W. 2006. Nonpharmaceutical interventions for pandemic influenza, international measures. Emerging Infectious Diseases, 12, 81–87.</p>
  <p>FEDERAL REPUBLIC OF NIGERIA 2013. Nigeria National Pandemic Influenza Preparedness and Response Plan.</p>
  <p>HOMELAND SECURITY COUNCIL USA 2006. National strategy for pandemic influenza Implementation plan.</p>
  <p>MALONE, J. D., BRIGANTIC, R., MULLER, G. A., GADGIL, A., DELP, W., MCMAHON, B. H., LEE, R., KULESZ, J. &amp; MIHELIC, F. M. 2009. US airport entry screening in response to pandemic influenza: modeling and analysis. Travel Med Infect Dis, 7, 181–191.</p>
  <p>MCLEOD, M., KELLY, H., WILSON, N. &amp; BAKER, M. G. 2008. Border control measures in the influenza pandemic plans of six South Pacific nations: a critical review. N Z Med J, 121, 62–72.</p>
  <p>MOUNIER-JACK, S., JAS, R. &amp; COKER, R. 2007. Progress and shortcomings in European national strategic plans for pandemic influenza. Bull World Health Organ, 85, 923–929.</p>
  <p>WORLD HEALTH ORGANISATION 2005. WHO global influenza preparedness plan. The role of WHO and recommendations for national measures before and during pandemics.</p>
  <p>WORLD HEALTH ORGANISATION 2017b. Pandemic Influenza Risk Management: A WHO guide to inform and harmonize national and international pandemic preparedness and response, Geneva: World Health Organisation.</p>
  <p>WORLD HEALTH ORGANISATION 2018a. A checklist for pandemic influenza risk and impact management: building capacity for pandemic response, Geneva, World Health Organisation.</p>
  <disp-formula>
   <bold>I
    <sc>nternational air travel and infectious diseases</sc>
   </bold>
  </disp-formula>
  <p>BRANNEN, D. E., ALHAMMAD, A., BRANUM, M. &amp; SCHMITT, A. 2016. International Air Travel to Ohio, USA, and the Impact on Malaria, Influenza, and Hepatitis A. Scientifica (Cairo), 2016, 8258946.</p>
  <disp-formula>
   <bold>P
    <sc>reparedness planning for infectious disease</sc>
   </bold>
  </disp-formula>
  <p>BERNITZ, B. K. 2008. Communicable disease policy development in response to changing European political frontiers in Finland, Norway, and Sweden. Scand J Public Health, 36, 875–878.</p>
  <p>CHIU, H. H., HSIEH, J. W., WU, Y. C., CHOU, J. H. &amp; CHANG, F. Y. 2014. Maintaining Human Health at the Border of Taiwan. Biosecurity and Bioterrorism-Biodefense Strategy Practice and Science, 12, 346–355.</p>
  <p>WARREN, A., BELL, M. &amp; BUDD, L. 2012. Model of health? Distributed preparedness and multi-agency interventions surrounding UK regional airports. Soc Sci Med, 74, 220–227.</p>
  <p>WORLD HEALTH ORGANISATION 2010a. Protocol for Assessing National Surveillance and Response Capacities for the International Health Regulations (2005).</p>
  <p>WORLD HEALTH ORGANISATION 2011. International Health Regulations (2005), IHR Core capacity monitoring framework: Checklist and Indicators for Monitoring Progress in the Development of IHR Core Capacities in States Parties.</p>
  <p>WORLD HEALTH ORGANISATION 2012. International health regulations (2005): a guide for public health emergency contingency planning at designated points of entry.</p>
  <p>WORLD HEALTH ORGANISATION 2013a. Activity Report, Review in activities 2012, Global Outbreak and Alert Response, World Health Organisation.</p>
  <p>WORLD HEALTH ORGANISATION 2013b. A Systematic Review of Public Health Emergency Operations Centers (EOC).</p>
  <p>WORLD HEALTH ORGANISATION 2016. Handbook for management of public health events on board ships.</p>
  <p>WORLD HEALTH ORGANISATION 2017a. Joint External Evaluation of IHR Core Capacities of the Federal Republic of Nigeria, Geneva: World Health Organisation.</p>
  <p>WORLD HEALTH ORGANISATION 2018b. Coordination of public health surveillance between points of entry and the national public health surveillance system Advising principles.</p>
  <p>WORLD HEALTH ORGANISATION 2018c. Joint external evaluation tool: International Health Regulations (2005), second edition, Geneva: World Health Organisation.</p>
  <p>WORLD HEALTH ORGANISATION 2009c. International Health Regulations (2005), Assessment tool for core capacity requirements at designated airports, ports, and ground crossings.</p>
  <disp-formula>
   <bold>S
    <sc>creening measures at ground crossing</sc>
   </bold>
  </disp-formula>
  <p>CLEARY, V., WYNNE-EVANS, E., FREED, J., FLEET, K., THORN, S. &amp; TURBITT, D. 2017. Ebola 2014: Setting up a port health screening programme at an international train station. J Bus Contin Emer Plan, 10, 177–187.</p>
  <disp-formula>
   <bold>S
    <sc>ever</sc> A
    <sc>cute</sc> R
    <sc>espiratory</sc> S
    <sc>yndrome</sc>
   </bold>
  </disp-formula>
  <p>BELL, D. M., WORLD HEALTH ORGANISATION WORKING GROUP ON, I. &amp; COMMUNITY TRANSMISSION OF, S. 2004. Public health interventions and SARS spread, 2003. Emerg Infect Dis, 10, 1900–1906.</p>
  <p>GLASS, K. &amp; BECKER, N. G. 2006. Evaluation of measures to reduce international spread of SARS. Epidemiol Infect, 134, 1092–1101.</p>
  <p>LEE, C. W., TSAI, Y. S., WONG, T. W. &amp; LAU, C. C. 2006. A loophole in international quarantine procedures disclosed during the SARS crisis. Travel Med Infect Dis, 4, 22–28.</p>
  <p>PITMAN, R. J., COOPER, B. S., TROTTER, C. L., GAY, N. J. &amp; EDMUNDS, W. J. 2005. Entry screening for severe acute respiratory syndrome (SARS) or influenza: policy evaluation. BMJ, 331, 1242–1243.</p>
  <p>SAMAAN, G., PATEL, M., SPENCER, J. &amp; ROBERTS, L. 2004. Border screening for SARS in Australia: what has been learnt? Med J Aust, 180, 220–223.</p>
  <p>ST JOHN, R. K., KING, A., DE JONG, D., BODIE-COLLINS, M., SQUIRES, S. G. &amp; TAM, T. W. 2005. Border screening for SARS. Emerg Infect Dis, 11, 6–10.</p>
  <p>TAN, C. C. 2006. SARS in Singapore—Key lessons from an epidemic. Annals Academy of Medicine Singapore, 35, 345–349.</p>
  <p>VENKATESH, S. &amp; MEMISH, Z. A. 2004. SARS: the new challenge to international health and travel medicine. East Mediterr Health J, 10, 655–662.</p>
  <p>WILDER-SMITH, A., GOH, K. T. &amp; PATON, N. I. 2003. Experience of severe acute respiratory syndrome in Singapore: Importation of cases, and defense strategies at the airport. Journal of Travel Medicine, 10, 259–262.</p>
  <p>WORLD HEALTH ORGANISATION 2003. WHO issues consensus document on the epidemiology of SARS. Wkly Epidemiol Rec, 78, 373–375.</p>
  <disp-formula>
   <bold>Z
    <sc>ika</sc> V
    <sc>irus</sc> D
    <sc>isease</sc>
   </bold>
  </disp-formula>
  <p>HO, L. L., TSAI, Y. H., LEE, W. P., LIAO, S. T., WU, L. G. &amp; WU, Y. C. 2017. Taiwan’s Travel and Border Health Measures in Response to Zika. Health Secur, 15, 185–191.</p>
  <p>HUANG, A. S. E., SHU, P. Y. &amp; YANG, C. H. 2016. A new reportable disease is born: Taiwan Centers for Disease Control’s response to emerging Zika virus infection. Journal of the Formosan Medical Association, 115, 223–225.</p>
 </app>
 <app id="app5-ijerph-16-04638">
  <title>Appendix E</title>
 </app>
 <app id="app6-ijerph-16-04638">
  <title>Appendix F</title>
 </app>
</app-group>
